165 related articles for article (PubMed ID: 36276116)
1. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Infante MS; Salmanton-García J; Fernández-Cruz A; Marchesi F; Jaksic O; Weinbergerová B; Besson C; Duarte RF; Itri F; Valković T; Szotkovski T; Busca A; Guidetti A; Glenthøj A; Collins GP; Bonuomo V; Sili U; Seval GC; Machado M; Cordoba R; Blennow O; Abu-Zeinah G; Lamure S; Kulasekararaj A; Falces-Romero I; Cattaneo C; Van Doesum J; Piukovics K; Omrani AS; Magliano G; Ledoux MP; de Ramon C; Cabirta A; Verga L; López-García A; Da Silva MG; Stojanoski Z; Meers S; Lahmer T; Martín-Pérez S; Dávila-Vals J; Van Praet J; Samarkos M; Bilgin YM; Karlsson LK; Batinić J; Nordlander A; Schönlein M; Hoenigl M; Ráčil Z; Mladenović M; Hanakova M; Zambrotta GPM; De Jonge N; Adžić-Vukičević T; Nunes-Rodrigues R; Prezioso L; Navrátil M; Marchetti M; Cuccaro A; Calbacho M; Giordano A; Cornely OA; Hernández-Rivas JÁ; Pagano L
Front Oncol; 2022; 12():992137. PubMed ID: 36276116
[TBL] [Abstract][Full Text] [Related]
2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
3. Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients.
Diefenbach C; Caro J; Koide A; Grossbard M; Goldberg JD; Raphael B; Hymes K; Moskovits T; Kreditor M; Kaminetzky D; Fleur-Lominy SS; Choi J; Thannickal SA; Stapleford KA; Koide S
medRxiv; 2021 Jun; ():. PubMed ID: 34100025
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Merli M; Ferrarini I; Merli F; Busca A; Mina R; Falini B; Bruna R; Cairoli R; Marchetti M; Romano A; Cavo M; Arcaini L; Trentin L; Cattaneo C; Derenzini E; Fracchiolla NS; Marchesi F; Scattolin A; Billio A; Bocchia M; Massaia M; Gambacorti-Passerini C; Mauro FR; Gentile M; Mohamed S; Della Porta MG; Coviello E; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Gherlinzoni F; Pagano L; Guidetti A; Bertù L; Corradini P; Passamonti F; Visco C
Hematol Oncol; 2023 Feb; 41(1):128-138. PubMed ID: 36265128
[TBL] [Abstract][Full Text] [Related]
5. Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.
Gavriatopoulou M; Terpos E; Kastritis E; Briasoulis A; Gumeni S; Ntanasis-Stathopoulos I; Sklirou AD; Malandrakis P; Eleutherakis-Papaiakovou E; Migkou M; Trougakos IP; Dimopoulos MA
Clin Exp Med; 2022 May; 22(2):319-323. PubMed ID: 34283338
[TBL] [Abstract][Full Text] [Related]
6. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Guven DC; Sahin TK; Akın S; Uckun FM
Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
[TBL] [Abstract][Full Text] [Related]
7. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
8. Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.
Puła B; Pruszczyk K; Pietrusza E; Morawska M; Piszczek W; Kalicińska E; Szeremet A; Tryc-Szponder J; Wąsik-Szczepanek E; Drozd-Sokołowska J; Krzemień H; Rejus A; Gajewska M; Wiśniewski K; Wysocki M; Majeranowski A; Paszkiewicz-Kozik E; Steckiewicz P; Szukalski Ł; Bołkun Ł; Długosz-Danecka M; Giannopoulos K; Jamroziak K; Lech-Marańda E; Hus I
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158826
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
10. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
11. Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review.
Jolles S; Giralt S; Kerre T; Lazarus HM; Mustafa SS; Ria R; Vinh DC
Front Oncol; 2023; 13():1098326. PubMed ID: 36824125
[TBL] [Abstract][Full Text] [Related]
12. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
Diamantopoulos PT; Stafylidis C; Vlachopoulou D; Kontandreopoulou CN; Giannakopoulou N; Vardaka M; Mpouhla A; Mastrogianni E; Variami E; Galanopoulos A; Pappa V; Psichogiou M; Hatzakis A; Viniou NA
Ther Adv Hematol; 2022; 13():20406207221090150. PubMed ID: 35646300
[TBL] [Abstract][Full Text] [Related]
15. Vaccination for SARS-CoV-2 in Hematological Patients.
Riccardi N; Falcone M; Yahav D
Acta Haematol; 2022; 145(3):257-266. PubMed ID: 35220303
[TBL] [Abstract][Full Text] [Related]
16. Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up.
Ye X; Xiao X; Li B; Zhu W; Li Y; Wu J; Huang X; Jin J; Chen D; Jin J; Huang J
Front Oncol; 2020; 10():1272. PubMed ID: 32719750
[No Abstract] [Full Text] [Related]
17. Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG).
Zhu H; Lu X; Zhang X; Hua H; Zhang J; Miao Y; Gu W; Xu M; Lu X; Li B; Wang C; Ni H; Qian J; Shi J; Xu M; Wu G; Zhang Y; Shen Q; Wang Z; Zhu J; Cheng Z; Zhuang W; Lin G; Hu Y; Shan Q; Chen Y; Qiu H; Li J; Shi W
Ann Hematol; 2024 Apr; ():. PubMed ID: 38649594
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
19. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
20. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
